Daniel McHugh

Yosemite partners with leading researchers and innovative entrepreneurs working to make cancer non-lethal within our lifetime. The firm deploys capital from early non-profit grantees through late-stage companies to fund advancements across the oncology ecosystem.

Yosemite partners with leading researchers and innovative entrepreneurs working to make cancer non-lethal within our lifetime. The firm deploys capital from early non-profit grantees through late-stage companies to fund advancements across the oncology ecosystem.

Emerson Collective is a company that invests in entrepreneurs and innovators driven by purpose and a sense of possibility, working to create a world of abundance for future generations. Complex challenges in education and economic mobility, immigration and the environment require audacious ideas, rigorous thinking and hard work. At EC, we are proud to partner with those taking big swings – with humility and hustle.

Founded in 1997, Pan-European VC Earlybird backs exceptional early-stage companies, supporting them through their growth and development phases and providing financial resources, strategic support, plus access to an international network and capital markets. Through two separate strategies, Earlybird focuses on tech-enabled businesses across software applications, infrastructure, and deep tech, while Earlybird Health focuses on life science breakthroughs accelerated by data-driven analytics and operations. Earlybird also has a pro-bono impact initiative, Vision Lab. With EUR 2.5 billion under management across fund streams and a history of 9 IPOs and 41 trade sales, Earlybird is among Europe’s most established and active venture capital firms. More information: www.earlybird.com X: https://x.com/EarlybirdVC LinkedIn:www.linkedin.com/company/earlybird-venture-capital Instagram: https://www.instagram.com/earlybirdvc/